LEO-153339

N/A

Report date: 2022/12/29 15:52:03
NME

Base Information

Drug NameLEO-153339
Drug Alias NameLEO-153339
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 17A inhibitors
TargetsInterleukin 17A
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeo Pharma Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A